Description
Anti-Cyclic Citrullinated Peptide
| Catalog number: | B2012264 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 5,000 IU/mL |
| Supplied as: | Liquid |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anticitrullinated protein antibody, aCCP, anti-CCP, CCP, Cyclic Citrullinated Peptide |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Popescu C, Zofot S, Bojinc V, Ionescu R. Anti-cyclic citrullinated peptide antibodies in psoriatic arthritiscross-sectional study and literature review J Med Life. 2013;6(4):376-82. Epub 2013 Dec 25.
- Mekic M, Hadzigrahic E. Anti-Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications Med Arch. 2020 Jun;74(3):183-186.
- Higashida-Konishi M, Izumi K, Tsukamoto M, Ohya H, Takasugi N, Hama S, Hayashi Y, Ushikubo M, Akiya K, Kazuhiro A, Okano Y, Oshima H. Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement Clin Rheumatol. 2020 Aug;39(8):2441-2448.
- Budhram A, Chu R, Rusta-Sallehy S, Ioannidis G, Denburg JA, Adachi JD, Haaland DA. Anti-cyclic citrullinated_peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis Lupus. 2014 Oct;23(11):1156-63.
- Kim KY, Lee YH. Anti-cyclic citrullinated_peptide antibody in psoriatic arthritis: a meta-analysis of its frequency and association with clinical features Z Rheumatol. 2020 May;79(4):397-403.
- Lu CH, Chen LF, Huang YM, Cheng CF, Hsieh SC, Li KJ. Anti-Cyclic Citrullinated_Peptide Antibodies Correlate to Ultrasound Synovitis in Rheumatoid Arthritis Better Than C-Reactive Protein J Clin Rheumatol. 2021 Dec 1;27(8):e412-e417.
- Yamazaki H, Kuroiwa T, Shinmura K, Yukioka M, Murata N. Prevalence of anti-cyclic citrullinated_peptide antibodies in patients with spondyloarthritis: A retrospective study Mod Rheumatol. 2021 Mar;31(2):458-461.
- Gavril BI, Ciofu C, Stoica V. Biomarkers in Rheumatoid Arthritis, what is new? J Med Life. 2016 Apr-Jun;9(2):144-8.
- Lpez-Longo FJ, Snchez-Ramn S, Carreo L. The value of anti-cyclic_citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors? Drug News Perspect. 2009 Nov;22(9):543-8.
